With high throughput DNA sequencing costs dropping below $1, 000 for human genomes, data storage, retrieval, and analysis are the major bottlenecks in biological studies. In order to address the large-data challenges, we advocate a clean separation between the evidence collection and the inference in variant calling. We define and implement a Genome Query Language (GQL) that allows for the rapid collection of evidence needed for calling variants. We provide a number of cases to showcase the use of GQL for complex evidence collection, such as the evidence for large structural variations. Specifically, typical GQL queries can be written in 5-10 lines of high level code, and search large data sets (100GB) in minutes. We also demonstrate its co...
Complete knowledge of the genetic variation in individual human genomes is a crucial foundation for ...
†These authors contributed equally. ∗To whom correspondence should be addressed. Motivation: Computa...
A high quality benchmark for small variants encompassing 88 to 90% of the reference genome has been ...
With DNA full sequencing costs dropping below $1, 000, two major application drivers are: finding th...
With high throughput DNA sequencing costs dropping below $1000 for human genomes, data storage, retr...
Abstract Background High throughput sequencing technologies have been increasingly used in basic gen...
Motivation: Improvement of sequencing technologies and data processing pipelines is rapidly providin...
* to whom correspondence should be addressed. The economy of human genome sequencing has catalyzed a...
Genotype Query Tools (GQT) is an indexing strategy that expedites analyses of genome-variation data ...
Next-generation sequencing (NGS) technologies and data processing pipelines are rapidly and inexpens...
MotivationComputational methods are essential to extract actionable information from raw sequencing ...
The economy of human genome sequencing has catalyzed ambitious efforts to interrogate the genomes of...
Population scale sequencing of whole human genomes is becoming economically feasible; however, data ...
Genotype Query Tools (GQT) were developed to discover disease-causing variations from billions of ge...
<div><p>Population scale sequencing of whole human genomes is becoming economically feasible; howeve...
Complete knowledge of the genetic variation in individual human genomes is a crucial foundation for ...
†These authors contributed equally. ∗To whom correspondence should be addressed. Motivation: Computa...
A high quality benchmark for small variants encompassing 88 to 90% of the reference genome has been ...
With DNA full sequencing costs dropping below $1, 000, two major application drivers are: finding th...
With high throughput DNA sequencing costs dropping below $1000 for human genomes, data storage, retr...
Abstract Background High throughput sequencing technologies have been increasingly used in basic gen...
Motivation: Improvement of sequencing technologies and data processing pipelines is rapidly providin...
* to whom correspondence should be addressed. The economy of human genome sequencing has catalyzed a...
Genotype Query Tools (GQT) is an indexing strategy that expedites analyses of genome-variation data ...
Next-generation sequencing (NGS) technologies and data processing pipelines are rapidly and inexpens...
MotivationComputational methods are essential to extract actionable information from raw sequencing ...
The economy of human genome sequencing has catalyzed ambitious efforts to interrogate the genomes of...
Population scale sequencing of whole human genomes is becoming economically feasible; however, data ...
Genotype Query Tools (GQT) were developed to discover disease-causing variations from billions of ge...
<div><p>Population scale sequencing of whole human genomes is becoming economically feasible; howeve...
Complete knowledge of the genetic variation in individual human genomes is a crucial foundation for ...
†These authors contributed equally. ∗To whom correspondence should be addressed. Motivation: Computa...
A high quality benchmark for small variants encompassing 88 to 90% of the reference genome has been ...